NCT05355701 2026-02-03
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
Pfizer
Phase 1 Recruiting
Pfizer
Pfizer
Pierre Fabre Medicament
Intergroupe Francophone de Cancerologie Thoracique
Pfizer
Pfizer
Deciphera Pharmaceuticals, LLC
University Health Network, Toronto
Abramson Cancer Center at Penn Medicine